Unlocking the Future of Surgical AI Market in United States 2024

The global AI-based surgical robots market has shown significant growth, with a market size of $5.7 billion in 2023, and is projected to grow at a compound annual growth rate (CAGR) of 16.2% from 2024 to 2032 . By 2024, the market is expected to reach $6.72 billion, increasing to $8.02 billion in 2025 . This growth is driven by technological advancements, the rising number of surgical procedures, and favorable government initiatives . Additionally, the integration of AI and machine learning, along with the increasing adoption of telemedicine and remote surgery, is expected to further propel the market to $15.1 billion by 2029 .

In the United States, the North American market for AI-based surgical robots held a 47% revenue share in 2022, valued at $3.27 billion . This dominance is attributed to the presence of key firms, advancements in AI and robotics, and the growing demand for minimally invasive therapies and robot-assisted surgeries . The region is expected to maintain its leading position due to the rising adoption of AI in healthcare and the increasing application of robotic surgery in various medical procedures, such as cardiothoracic, colorectal, and gynecological surgeries .

The growth in both the global and U.S. markets is fueled by several factors. Technological advancements, such as AI and machine learning integration, are enhancing the capabilities of surgical robots, making them more precise and efficient . Additionally, the increasing number of surgical procedures, driven by a growing aging population and the prevalence of chronic diseases, is boosting demand . Furthermore, the shortage of medical professionals is accelerating the adoption of robotic surgeries, as they offer a solution to enhance surgical efficiency and outcomes . These factors collectively contribute to the robust growth projections for the AI-based surgical robots market.

The global AI-based surgical robots market has shown significant growth, with a market size of $5.7 billion in 2023, and is projected to grow at a compound annual growth rate (CAGR) of 16.2% from 2024 to 2032 . By 2024, the market is expected to reach $6.72 billion, increasing to $8.02 billion in 2025 . This growth is driven by technological advancements, the rising number of surgical procedures, and favorable government initiatives . Additionally, the integration of AI and machine learning, along with the increasing adoption of telemedicine and remote surgery, is expected to further propel the market to $15.1 billion by 2029 .

In the United States, the North American market for AI-based surgical robots held a 47% revenue share in 2022, valued at $3.27 billion . This dominance is attributed to the presence of key firms, advancements in AI and robotics, and the growing demand for minimally invasive therapies and robot-assisted surgeries . The region is expected to maintain its leading position due to the rising adoption of AI in healthcare and the increasing application of robotic surgery in various medical procedures, such as cardiothoracic, colorectal, and gynecological surgeries .

Market Segmentation Analysis of the AI-Based Surgical Robots Market in the United States

The AI-based surgical robots market is a rapidly evolving sector within the healthcare industry, driven by advancements in artificial intelligence, robotics, and minimally invasive surgical techniques. This analysis focuses on the market segmentation within the United States, leveraging geographical, product type, application, and level of automation segments to provide a comprehensive understanding of the market dynamics.

Key Segments

1. Geographical Segmentation: The United States, as part of the North American region, dominates the global AI-based surgical robots market. In 2024, North America accounted for approximately 51% of the global market revenue, with the U.S. being the primary contributor. This dominance is attributed to the region’s advanced healthcare infrastructure, high adoption rates of AI technologies, and the presence of key market players like Intuitive Surgical, Inc., and Medtronic.

2. Product Type Segmentation: The market is segmented into services, instruments, and accessories. The instruments and accessories segment held the largest market share in 2022, driven by the increasing acceptance of robot-assisted surgeries integrated with AI systems. Services, which include patient data analysis and surgical assistance, are also growing in demand.

3. Application Segmentation: The applications of AI-based surgical robots span orthopedics, neurology, urology, gynecology, and other surgical fields. Robotic surgery is particularly prevalent in cardiothoracic, colorectal, and hip & knee replacement surgeries in the U.S..

4. Level of Automation Segmentation: This segment includes semi-autonomous, autonomous, and telerobotic systems. Semi-autonomous systems, which assist surgeons with specific tasks, held the largest market share in 2023, accounting for over 60% of revenue. Autonomous and telerobotic systems are expected to grow significantly due to advancements in AI and machine learning.

Segment Comparison

Analysis

Geographical Segment (United States)

The U.S. holds a dominant position in the AI-based surgical robots market due to its advanced healthcare infrastructure, high per capita income, and favorable reimbursement policies. The presence of key players like Intuitive Surgical and Medtronic further strengthens the market. However, the high cost of AI-based surgical systems and the need for specialized training for surgeons pose challenges to widespread adoption.

Product Type Segment

The instruments and accessories segment is the largest, driven by the increasing acceptance of robot-assisted surgeries. Services, particularly those involving patient data analysis and surgical assistance, are also growing. The challenge lies in ensuring the affordability and accessibility of these high-cost products and services, especially in smaller healthcare facilities.

Application Segment

The demand for AI-based surgical robots is high in specialized fields like orthopedics, neurology, and gynecology. These applications offer precision and reduced recovery times, making them attractive to both surgeons and patients. However, the complexity of integrating AI systems into existing surgical workflows remains a barrier.

Level of Automation Segment

Semi-autonomous systems currently dominate due to their ability to assist surgeons without fully replacing human expertise. Autonomous and telerobotic systems are expected to grow, driven by advancements in AI and the need for remote surgical capabilities. The primary challenge is ensuring the safety and reliability of fully autonomous systems, which require rigorous testing and regulatory approval.

The AI-based surgical robots market in the United States is highly competitive, with several key players driving innovation and adoption. These companies are characterized by their technological advancements, strong market presence, and diverse product portfolios. Below is an overview of the core players, their characteristics, advantages, and disadvantages.

Key Players in the Surgical AI Market

1. Intuitive Surgical, Inc.

   • Characteristics: Leader in robotic-assisted surgery with its da Vinci Surgical System, offering high precision and versatility across multiple surgical specialties.
   • Advantages: Proven track record, extensive clinical data, and widespread adoption in hospitals and surgical centers.
   • Disadvantages: High cost of systems and limited adaptability to non-surgical applications3.

2. Medtronic plc

   • Characteristics: Strong R&D capabilities and a diverse portfolio of surgical robotics and AI-driven solutions.
   • Advantages: Modular design, advanced AI integration, and a broad range of applications.
   • Disadvantages: Slower adoption rates in emerging markets compared to competitors7.

3. Stryker Corporation

   • Characteristics: Focus on minimally invasive surgical robots, with a strong presence in orthopedic and spine surgeries.
   • Advantages: High precision in orthopedic procedures, user-friendly design, and strong market positioning.
   • Disadvantages: Limited penetration in non-orthopedic surgical fields1.

4. Accuray Incorporated

   • Characteristics: Specializes in precision radiation therapy robots, integrating AI for enhanced treatment planning.
   • Advantages: High accuracy in radiation therapy, niche market leadership.
   • Disadvantages: Limited applications in broader surgical fields2.

5. Zimmer Biomet Holdings Inc.

   • Characteristics: Expertise in orthopedic surgical robots, with a strong emphasis on joint replacement surgeries.
   • Advantages: Strong focus on orthopedic applications, high precision in joint surgeries.
   • Disadvantages: Limited presence in non-orthopedic surgical robotics2.

6. Activ Surgical, Inc.

   • Characteristics: Focus on real-time AI-driven surgical decision support systems.
   • Advantages: Innovative technology, real-time data analysis, and enhanced surgical decision-making.
   • Disadvantages: Smaller market share compared to established players1.

7. CMR Surgical, Inc.

   • Characteristics: Versatile Versius surgical robot with AI integration for enhanced precision.
   • Advantages: Compact design, AI-enhanced precision, and adaptability to various surgical procedures.
   • Disadvantages: Limited brand recognition in the U.S. market2.

8. Transenterix, Inc. (Asensus Surgical Inc.)

   • Characteristics: Focus on minimally invasive surgical robots with AI capabilities.
   • Advantages: Cost-effective solutions, minimally invasive capabilities.
   • Disadvantages: Financial challenges and smaller market presence2.

9. Smith and Nephew plc

   • Characteristics: Strong presence in orthopedic and sports medicine robotics.
   • Advantages: Expertise in orthopedic applications, user-friendly systems.
   • Disadvantages: Limited focus on AI-driven surgical solutions1.

10. Johnson & Johnson

    • Characteristics: Diversified healthcare portfolio with investments in AI-driven surgical robotics.
    • Advantages: Strong R&D capabilities, diversified product offerings.
    • Disadvantages: Relatively new entrant in the surgical robotics space2.

Players Comparison

Analysis of the Competitive Landscape

The competitive landscape of the U.S. surgical AI market is shaped by the dominance of established players like Intuitive Surgical, Medtronic, and Stryker, which leverage their technological expertise and strong market presence to maintain leadership3. Emerging players such as Activ Surgical and CMR Surgical are driving innovation with AI-driven solutions, focusing on real-time decision support and enhanced precision1.

The U.S. market benefits from a robust regulatory framework, with the FDA streamlining approvals for AI-driven surgical technologies, such as the MIRA Surgical System in 20245. Additionally, the increasing adoption of minimally invasive procedures and the growing demand for precision in surgeries are driving market growth3.

However, challenges such as high costs and the need for specialized training may limit broader adoption. The market is also witnessing strategic collaborations and partnerships, with companies like Johnson & Johnson and Medtronic expanding their portfolios through acquisitions and innovations1.

The AI-based surgical robots market in the United States is experiencing significant growth, driven by several key trends. One of the most prominent trends is the rising adoption of minimally invasive surgeries, which are less traumatic for patients and result in quicker recovery times. AI-based surgical robots offer superior control and precision, making them ideal for such procedures3. Another major trend is the integration of AI and machine learning (ML) technologies into surgical robotic systems, which is transforming their capabilities. These advancements enable better decision-making, personalized surgical experiences, and improved outcomes9. Additionally, the regulatory framework in the U.S. supports the use of AI-based surgical technology, with streamlined FDA approval processes hastening the release of innovative products like the MIRA Surgical System5.

The primary drivers of these trends include the increasing demand for minimally invasive surgeries, advancements in AI technology, and the presence of a robust healthcare infrastructure in the U.S.4. The willingness of hospitals and surgical centers to adopt cutting-edge solutions, coupled with favorable government regulations, further accelerates market growth7.

The United States is a dominant player in the AI-based surgical robots market, driven by its advanced healthcare infrastructure, high adoption of cutting-edge technologies, and favorable regulatory environment4. The demographic characteristics of this market are influenced by the increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular conditions, which often require surgical intervention5. For instance, the U.S. performs approximately 40 to 50 million major surgical procedures annually, many of which benefit from the precision and accuracy of AI-assisted robotics5.

The aging population in the U.S. also plays a significant role in driving demand for surgical AI solutions. Older adults are more likely to require surgical procedures, particularly for conditions like hip and knee replacements, which are increasingly performed using robotic systems1. Additionally, the shortage of qualified surgeons, projected to reach between 37,800 and 124,000 within 12 years, further underscores the need for AI-powered surgical assistants to enhance procedural efficiency and reduce human error7.

The demographic trends in the U.S. significantly influence purchasing behavior and market demand for surgical AI technologies. The rising adoption of minimally invasive procedures, which offer quicker recovery times and reduced trauma, aligns with the preferences of an aging population and patients seeking less invasive treatment options3.

The decision-making process for AI-based surgical robots in the U.S. is primarily driven by healthcare providers, including hospitals and ambulatory surgical centers. These institutions evaluate the technology based on its ability to enhance surgical precision, reduce recovery times, and improve patient outcomes. The process often involves a detailed assessment of the robot's integration with existing systems, cost-effectiveness, and compliance with regulatory standards6. Additionally, the growing awareness among patients about the benefits of robotic-assisted surgeries influences providers to adopt these technologies to meet patient expectations8.

The key drivers of purchasing behavior in this market include technological advancements, healthcare reimbursement policies, the prevalence of chronic diseases, and patient awareness. Innovations such as AI-powered real-time decision support and robotic assistance are critical factors7. Well-established reimbursement policies in North America encourage investment in high-cost surgical robots6. The high prevalence of chronic diseases like cancer and cardiovascular conditions drives demand for advanced surgical solutions8.

The U.S. market exhibits a strong preference for AI-integrated surgical robots, particularly in applications like orthopedics, neurology, and urology2. The instruments and accessories segment dominates due to the rising acceptance of robot-based surgeries1.

The U.S. regulatory framework, led by the FDA, plays a pivotal role in the AI-based surgical robots market. The FDA has streamlined approval processes for medical products, including AI-driven surgical technologies, which has expedited their market entry. For example, in 2024, the FDA approved the MIRA Surgical System, a groundbreaking miniRAS device for colectomy procedures5. This reflects a proactive approach to fostering innovation in surgical AI.

Regulations significantly influence market dynamics by lowering barriers to entry for new technologies and encouraging competition. The favorable regulatory environment in the U.S. has attracted major players like Intuitive Surgical and Medtronic, fostering innovation and market growth7. However, the integration of AI in surgery also raises ethical and legal challenges, particularly concerning liability, data privacy, and autonomous decision-making9.

The regulatory landscape presents both risks and opportunities. On one hand, stringent data privacy and liability regulations could increase compliance costs for manufacturers9. On the other hand, the streamlined approval process and supportive policies create opportunities for rapid market entry and innovation, particularly for startups10.

The United States is a dominant force in the AI-based surgical robots market, contributing approximately 40% of the global market share 7. This leadership is underpinned by a robust healthcare infrastructure, high adoption rates of advanced technologies, and favorable government regulations. The U.S. regulatory framework, particularly the FDA’s streamlined approval processes, has accelerated the introduction of innovative surgical robots, such as the MIRA Surgical System approved in 2024 5. Additionally, the rising prevalence of chronic diseases like cancer, cardiovascular conditions, and obesity-related disorders has increased the demand for robotic-assisted surgeries 6.

Economic trends in the U.S. healthcare sector, such as the growing emphasis on minimally invasive surgeries and the integration of AI technologies, are significantly influencing the surgical AI market. Minimally invasive procedures, expected to generate $10.2 billion by 2024, are gaining traction due to their benefits, including faster recovery and reduced scarring 4. The adoption of AI-powered surgical systems is further driven by the increasing demand for precision and efficiency in surgical interventions. For instance, the introduction of advanced systems like US Medical Innovations’ robotic AI surgical system in 2024 highlights the synergy between economic investment and technological innovation 1.

The AI-based surgical robots market in the United States is characterized by rapid advancements in robotic-assisted surgery and AI integration. Technologies such as minimally invasive surgical systems, robotic-assisted total knee and hip replacements, and AI-driven surgical planning tools are gaining traction. For instance, the MIRA Surgical System, approved by the FDA in 2024, represents a breakthrough in miniaturized robotic-assisted surgery, particularly for colectomy procedures 5. Additionally, innovations like cold atmospheric plasma technology, which targets microscopic tumor cells without damaging surrounding tissue, are reshaping surgical precision 1.

Key competitors in the U.S. market are leveraging advanced technologies to differentiate themselves. Intuitive Surgical, for example, has performed over 12 million robotic surgery procedures, highlighting its dominance in the sector 1. The integration of AI systems into robotic surgery, as seen with US Medical Innovations' 2024 launch, underscores the trend toward combining robotics with AI for enhanced surgical outcomes 1. These technologies offer advantages such as higher precision, reduced recovery times, and personalized surgical plans, which are increasingly demanded by both healthcare providers and patients.

Technological advancements are significantly influencing the market structure and consumer behavior. The U.S. market, accounting for approximately 40% of the global AI in operating room market, is driven by well-established healthcare infrastructure and favorable regulatory frameworks 7. The rising prevalence of chronic diseases, such as cancer and cardiovascular conditions, has accelerated the adoption of AI-based surgical robots, particularly for complex procedures 6. Patients are increasingly aware of the benefits of robotic-assisted surgeries, such as minimal scarring and faster recovery, which is pushing healthcare providers to adopt these technologies 6.

Consumer feedback in the AI-based surgical robots market in the United States highlights both positive and negative aspects. On the positive side, there is a strong appreciation for the precision and efficiency of AI-driven surgical systems, particularly in minimally invasive procedures, which reduce recovery times and improve patient outcomes 3. The regulatory support from agencies like the FDA has also been a significant factor, with streamlined approval processes enabling faster market entry of innovative technologies such as the MIRA Surgical System 5. However, concerns remain regarding the high costs of these systems and the need for specialized training for healthcare professionals, which can limit accessibility and adoption in smaller healthcare facilities.

To address consumer concerns, companies could focus on reducing costs through economies of scale and partnerships with healthcare providers. Additionally, developing more user-friendly systems and comprehensive training programs could enhance adoption rates, especially in smaller facilities. Expanding into emerging markets, as seen with Stryker Corporation, could also drive growth and innovation 7. The competitive landscape, driven by key players like Intuitive Surgical and Medtronic, suggests continued innovation and growth in this market 7.